Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01876784
Title Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
Acronym VERIFY
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA | SWE | POL | ITA | FRA | ESP | DNK | CZE | BRA


No variant requirements are available.